Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELUW) Assets (2020 - 2025)

Historic Assets for Celularity (CELUW) over the last 6 years, with Q3 2025 value amounting to $114.2 million.

  • Celularity's Assets fell 1133.27% to $114.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $114.2 million, marking a year-over-year decrease of 1133.27%. This contributed to the annual value of $132.7 million for FY2024, which is 778.86% down from last year.
  • Latest data reveals that Celularity reported Assets of $114.2 million as of Q3 2025, which was down 1133.27% from $120.3 million recorded in Q2 2025.
  • In the past 5 years, Celularity's Assets ranged from a high of $448.3 million in Q3 2021 and a low of $114.2 million during Q3 2025
  • Moreover, its 5-year median value for Assets was $157.2 million (2023), whereas its average is $252.6 million.
  • In the last 5 years, Celularity's Assets surged by 23433.45% in 2022 and then crashed by 6412.34% in 2023.
  • Celularity's Assets (Quarter) stood at $414.1 million in 2021, then decreased by 3.15% to $401.1 million in 2022, then crashed by 64.12% to $143.9 million in 2023, then dropped by 7.79% to $132.7 million in 2024, then fell by 13.9% to $114.2 million in 2025.
  • Its Assets stands at $114.2 million for Q3 2025, versus $120.3 million for Q2 2025 and $128.9 million for Q1 2025.